ID

30240

Descrizione

https://clinicaltrials.gov/show/NCT00989664 Laboratory Results Weeks 8 and 9 Study ID: 104504 Clinical Study ID: BEX104504 Study Title: Multicenter, Pivotal Phase III Study of Iodine-131 Anti-B1 Antibody (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas that have Transformed to Higher Grade Histologies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00989664 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

collegamento

https://clinicaltrials.gov/show/NCT00989664

Keywords

versioni (1)

1. 23/05/18 23/05/18 -

Titolare del copyright

GlaxoSmithKline (GSK)

Caricato su

23 maggio 2018

DOI

Per favore, per richiedere un accesso.

Licenza